Company: KROS
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-037982
Chunk: 56

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 56
---
.(1)    | ​ | ​ | ​               | ​ |       — | ​ | ​ | ​ | ​               | $ | 510,000 | ​ | ​ | ​ | —                                      | ​ |
| Simon Cooper, M.B.B.S.  | ​ | ​ | ​               | $ | 470,000 | ​ | ​ | ​ | ​               | $ | 484,100 | ​ | ​ | ​ | 3%                                     | ​ |
| Christopher Rovaldi     | ​ | ​ | ​               | $ | 500,000 | ​ | ​ | ​ | ​               | $ | 540,000 | ​ | ​ | ​ | 8%                                     | ​ |

(1) Dr. Chyung was appointed to serve as our Chief Medical Officer, effective November 1, 2024. The Compensation Committee determined that Dr. Chyung’s base salary was appropriate in light of market data and Dr. Chyung’s skills and experience. Annual Cash Performance Bonus Bonus Targets for 2024 Each of our named executive officers is eligible to receive an annual performance bonus based on the achievement of Company-wide annual performance goals determined by our Compensation Committee. Each named executive officer is assigned a target bonus expressed as a percentage of his base salary. The Compensation Committee and Board determined that the bonus targets from 2023 for our named executive officers, other than our Chief Executive Officer, remained aligned with competitive trends and appropriate for the Company, and as a result, were unchanged for 2024. As such, the target bonus amounts for Mr. Regnante, Dr. Cooper and Mr. Rovaldi for 2024 were set at 40%, 40% and 50%, respectively. In February 2024, upon the recommendation of our Compensation Committee, our Board reviewed the bonus

37

TABLE OF CONTENTS

target of our Chief Executive Officer and approved an increase to his bonus target from 50% to 65%. Based on our Compensation Committee’s subjective judgement, our Compensation Committee determined this increase was appropriate in light of our Chief Executive Officer’s individual performance. The Compensation Committee determined Dr. Chyung’s target bonus amount in connection with his commencement of employment as our Chief Medical Officer, effective November 1, 2024. Dr. Chyung’s employment agreement provides that Dr. Chyung is entitled to a target bonus amount of 40% of his base salary. However, pursuant to his employment agreement, for 2024,